Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)
Completed · NCT05067478
Conditions: Overactive Bladder
At a glance
- Research payments reported, 2025
- $60,143
- U.S. investigators named
- 15
- Sites paid
- 14
- Planned or actual enrollment
- 403
About the trial
- Sponsor
- Urovant Sciences GmbH
- Tested
- Vibegron (drug)
- Dates
- Started 2021-10-28; completion 2024-07-26
- Results posted
- Not yet
This study will evaluate the treatment satisfaction, discontinuation, reasons for discontinuation, quality of life, healthcare resource utilization, and safety with Vibegron for the treatment of OAB in the context of real-world clinical practice.
From ClinicalTrials.gov, last updated 2024-12-27. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Sumitomo Pharma America, Inc. reported $60,143 in research payments for this study in 2025 (86 payments).
Products named: Gemtesa
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Thomas C. Fiel, D.O. Sports Medicine · Tempe, AZ
- Belkis Delgado, M.D. Internal Medicine · Miami Springs, FL
- Robinson N. Koilpillai, M.D. Family Medicine · Winter Haven, FL
- Raveen Syan, MD Urology · Miami, FL
- Marian G. Acevedo Alvarez, MD Urogynecology · Maywood, IL
- Casey Kowalik, MD Urology · Kansas City, KS
- Kevin J. Cline, MD Urology · Shreveport, LA
- Nissrine A. Nakib, M.D. Urology · Minneapolis, MN
- Catherine A. Matthews, MD Urogynecology · Winston Salem, NC
- Donald J. Debrakeleer, DO Urogynecology · Pennington, NJ
- Steven Sussman, M.D. OB-GYN (Obstetrics & Gynecology) · Lawrenceville, NJ
- Bilal I. Chughtai, MD Urology · New York, NY
- Daniel M. Katz, MD Urology · Poughkeepsie, NY
- Adonis K. Hijaz, M.D. Urology · Cleveland, OH
- Keith R. Xavier, MD Urogynecology · Arlington, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Weill Medical College of Cornell University $21,254
- University of Miami $13,189
- University of Kansas Medical Center Research Institute Inc $6,248
- University Hospitals Cleveland Medical Center $5,450
- Cognitive Clinical Trials LLC $4,862
- Loyola University of Chicago $2,249
- Clinical Research of Central Florida $1,800
- Capital Health Regional Medical Center, NJ $1,382
- Regents of the University of Minnesota $1,334
- Premier Medical Group of the Hudson Valley $750
- Ochsner Lsu Health Shreveport St Mary Medical Center LLC $500
- Upnt Research Institute LLC $500
- Wake Forest University Health Sciences $350
- South Florida Research Phase I-Iv $275
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.